PROLONG Prospective, Multi-center, Open-label, Post-market Study

NACompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

April 16, 2019

Primary Completion Date

November 15, 2021

Study Completion Date

November 15, 2021

Conditions
Chronic Pain
Interventions
DEVICE

Burst-capable SCS system

Subjects will be given Burst stimulation using a market-released Abbott SCS system. Burst stimulation may be achieved through surgical or non-surgical means.

DEVICE

DRG Stimulator

Subjects will be implanted with a market-released Abbott DRG stimulation system.

Trial Locations (21)

10022

Ainsworth Institute of Pain Management, New York

12208

Albany Medical College at Albany Medical Center, Albany

15212

Allegheny General Hospital Department of Neurosurgery, Pittsburgh

17604

Center for Interventional Pain and Spine, Lancaster

25301

The Spine & Nerve Center of St. Francis Hospital, Charleston

25702

St. Mary's Hospital, Huntington

30281

Pain Care, LLC, Stockbridge

33486

Boca Raton Regional Hospital, Boca Raton

55435

Nura, Edina

80528

Front Range Pain Medicine, Fort Collins

89511

Nevada Advanced Pain Specialists, Reno

92009

Coastal Pain & Spinal Diagnostics Medical Group, Carlsbad

92037

UC San Diego Center for Pain Medicine, La Jolla

92660

Newport Beach Headache & Pain, Newport Beach

93010

Spanish Hills Interventional Pain Specialists, Camarillo

94104

Pacific Research Institute, San Francisco

94558

Napa Valley Orthopedic Medical Group, Napa

95661

Spine & Nerve Diagnostic Center, Roseville

97701

Northwest Brain & Spine, Bend

02115

Brigham & Women's Hospital, Boston

07013

Garden State Pain Control, Clifton

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY